Glycoside Steroids TRIZ Cases
- OCT4 Interaction Inhibitors for c-MYC-Driven Cancer Resistance
Compounds that block OCT4 binding to MAPKAPK2 or DNA-PKcs suppress c-MYC activation and help restore therapy response in cancer.
- Mogroside V Biocatalysis for High-Purity Siamenoside I Sweetener
Beta-galactosidase converts mogroside V into high-purity Siamenoside I, improving monk fruit sweetness profile while reducing contaminants.
- Polypodoside Sweet Modifiers for Sugar-Like Taste and Onset
Polypodoside compounds pair with high-intensity sweeteners to create a more sugar-like taste with less aftertaste.
- Iso-mogroside V Sweetener Flavor Intensity
Iso-mogroside V intensifies sweet taste and extends flavor sensation while reducing calorie load from lower concentrations.
- Luo Han Guo Sweetening Composition Decolorization Process
A Luo Han Guo sweetening composition achieves light color through controlled heating and filtration steps.
- Novel Mogrosides Purification via HPLC Chromatography
Sequential silica gel and reverse phase chromatography removes impurities that degrade flavor profiles while maintaining extraction efficiency.
- Sweetening Compound Formula I for Rapid Onset and Aftertaste Masking
Formula I compounds resolve delayed sweetness delivery and lingering aftertastes through dynamic receptor binding kinetics.
- Steroid Amphiphiles for Membrane Protein Stability
Rigid steroid amphiphiles solubilize membrane proteins, preventing denaturation and aggregation common with traditional detergents.
- SLOS Diagnosis via Urine Metabolic Marker Detection
Liquid chromatography mass spectrometry detects specific urine bile acid intermediates to diagnose Smith-Lemli-Opitz syndrome without invasive tissue sampling.
- Ginsenoside Rh2 Stereochemistry Inversion for Cancer Cytotoxicity
Inverting the C-24 stereocenter of 20(R)-Rh2 enhances cytotoxicity while maintaining non-toxicity to normal cells.